Almac Diagnostic Services Limited
Records under this name other than the patents Almac Diagnostic Services Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 5 of 5 · Back to Almac Diagnostic Services Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,091,809 | Molecular diagnostic test for cancer Formerly held Lapsed on the fee record Ended Aug 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | From the USPTO record |
| US 10,280,468 | Molecular diagnostic test for predicting response to anti-angiogenic drugs and prognosis of cancer Lapsed on the fee record Ended May 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2023 | From the USPTO record |
| US 10,260,097 | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent Lapsed on the fee record Ended Apr 16, 2023 · High confidence | Lapsed on the fee record | Ended Apr 16, 2023 | High confidence |
| US 10,196,691 | Colon cancer gene expression signatures and methods of use Lapsed on the fee record Ended Feb 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2023 | From the USPTO record |
| US 10,196,697 | Prostate cancer classification Lapsed on the fee record Ended Feb 5, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2023 | From the USPTO record |